Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/36472
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorTobón Zapata, Gloria Elena-
dc.contributor.authorHenao Castaneda, Isabel Cristina-
dc.contributor.authorBenavides Arevalo, Julie Fernanda-
dc.contributor.authorFranco, C. A.-
dc.contributor.authorLeon, I. E.-
dc.contributor.authorEtcheverry, S. B.-
dc.date.accessioned2023-08-31T18:18:43Z-
dc.date.available2023-08-31T18:18:43Z-
dc.date.issued2013-
dc.identifier.citationDi Virgilio, A. L., León, I. E., Franca, C. A., Henao, I., Tobón, G., & Etcheverry, S. B. (2013). Cu(Nor)2·5H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell cultures. Molecular and cellular biochemistry, 376(1-2), 53–61. https://doi.org/10.1007/s11010-012-1548-8spa
dc.identifier.issn0300-8177-
dc.identifier.urihttps://hdl.handle.net/10495/36472-
dc.description.abstractABSTRACT: Norfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections. In this article, we studied the potential antitumoral action of a complex of Norfloxacin with Cu(II), Cu(Nor)25H2O on osteosarcoma cells (UMR106) and calvaria-derived cells (MC3T3-E1), evaluating its cytotoxicity and genitoxicity. We have also elucidated the more stable conformation of this complex under physiologic conditions by Molecular Dynamic simulations based on the model of the canonical ensemble and PM6 force field. When solvent effect was taken into account, the complex conformation with both carbonyl groups in opposite sides displayed lower energy. Cu(Nor)25H2O caused an inhibitory effect on the proliferation on both cell lines from 300 lM (P\0.01). Nevertheless, the decline on cell proliferation of UMR106 cells was more pronounced (45 % vs basal) than in MC3T3-E1 cells (20 % vs basal) at 300 lM (P\0.01). Cu(Nor)25H2O altered lysosomal metabolism (Neutral Red assay) in a dose-dependent manner from 300 lM (P\0.001). Morphological studies showed important transformations that correlated with a decrease in the number of cells in a dose-dependent manner. Moreover, Cu(Nor)25H2O caused statistically significant genotoxic effects on both osteoblast cell lines in a lower range of concentrations (Micronucleus assay) (P\0.05 at 10 lM, P\0.001 from 25 to 50 lM). UMR106 cells displayed a dose-related genotoxic effect between 5 and 25 lM while the MC3T3-E1 cells showed a narrower concentration dependent range. Altogether, these results suggest that Cu(Nor)25H2O is a good candidate to be further evaluated for alternative therapeutics in cancer treatment.spa
dc.format.extent9spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherSpringerspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleCu(Nor)2_5H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell culturesspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupDiseño y Formulación de Medicamentos Cosméticos y Afinesspa
dc.identifier.doi10.1007/s11010-012-1548-8-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1573-4919-
oaire.citationtitleMolecular and Cellular Biochemistryspa
oaire.citationstartpage53spa
oaire.citationendpage61spa
oaire.citationvolume376spa
oaire.citationissue1-2spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
dc.publisher.placeNueva York, Estados Unidosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsAntineoplásicos-
dc.subject.decsAntineoplastic Agents-
dc.subject.decsNeoplasias Óseas - Quimioterapia-
dc.subject.decsBone Neoplasms - Drug Therapy-
dc.subject.decsLínea Celular Tumoral-
dc.subject.decsCell Line, Tumor-
dc.subject.decsProliferación Celular-
dc.subject.decsCell Proliferation-
dc.subject.decsComplejos de Coordinación-
dc.subject.decsCoordination Complexes-
dc.subject.decsCobre - farmacología-
dc.subject.decsCopper - pharmacology-
dc.subject.decsEnsayos de Selección de Medicamentos Antitumorales - métodos-
dc.subject.decsDrug Screening Assays, Antitumor - methods-
dc.subject.decsLisosomas - efectos de los fármacos-
dc.subject.decsLysosomes - drug effects-
dc.subject.decsRatones-
dc.subject.decsMice-
dc.subject.decsPruebas de Micronúcleos-
dc.subject.decsMicronucleus Tests-
dc.subject.decsSimulación de Dinámica Molecular-
dc.subject.decsMolecular Dynamics Simulation-
dc.subject.decsPruebas de Mutagenicidad-
dc.subject.decsMutagenicity Tests-
dc.subject.decsNorfloxacino-
dc.subject.decsNorfloxacin-
dc.subject.decsOsteoblastos-
dc.subject.decsOsteoblasts-
dc.subject.decsRatas-
dc.subject.decsRats-
dc.description.researchgroupidCOL0003623spa
dc.relation.ispartofjournalabbrevMol. Cell. Biochem.spa
Aparece en las colecciones: Artículos de Revista en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
TobonGloria_2013_Cu(Nor).pdfArtículo de investigación386.65 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons